pharma · Facioscapulohumeral Muscular Dystrophy (FSHD) · Facioscapulohumeral Muscular Dystrophy 1 (FSHD1) · FULC
Fulcrum Therapeutics
Fulcrum Therapeutics clinical programs — 12 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 26 Landsdowne St, Cambridge, Massachusetts 02139, US
- Founded
- 2016
- Employees
- 73
- Programs
- 12
- Drugs
- 8
- Patents
- 11
Fulcrum Therapeutics projects
12 ClinicalTrials.gov programs sponsored by Fulcrum Therapeutics.
Fulcrum Therapeutics has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
1821-FSH-301
Fulcrum Therapeutics
Facioscapulohumeral Muscular Dystrophy (FSHD)
1 trial -
Losmapimod
Fulcrum Therapeutics
Facioscapulohumeral Muscular Dystrophy (FSHD)
2 trials -
Losmapimod oral tablet
Fulcrum Therapeutics
COVID-19
1 trial -
ACE393
Fulcrum Therapeutics
Campylobacter Infection
1 trial -
Losmapimod
Fulcrum Therapeutics
Facioscapulohumeral Muscular Dystrophy 1
1 trial -
Losmapimod
Fulcrum Therapeutics
Facioscapulohumeral Muscular Dystrophy 1 (FSHD1)
1 trial -
Losmapimod
Fulcrum Therapeutics
Facioscapulohumeral Muscular Dystrophy 1 (FSHD1)
1 trial -
Losmapimod oral tablet
Fulcrum Therapeutics
Facioscapulohumeral Muscular Dystrophy (FSHD)
1 trial -
Pociredir
Fulcrum Therapeutics
Sickle Cell Disease
2 trials -
FTX-6058/placebo oral capsule(s)
Fulcrum Therapeutics
Healthy Adult Subjects
1 trial -
Losmapimod 15 mg oral tablet
Fulcrum Therapeutics
Healthy Adult Subjects
1 trial -
Pociredir oral capsule(s)
Fulcrum Therapeutics
Sickle Cell Disease
1 trial
Frequently asked questions
How many clinical projects does Fulcrum Therapeutics have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.